Farallon Capital Partners L.P. 13D and 13G filings for Perspective Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:10 pm Purchase |
2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX |
Farallon Capital Partners L.P. | 5,316,227 7.600% |
252,000 (+4.98%) |
Filing |
| 2024-11-14 8:21 pm Purchase |
2024-11-08 | 13G | Perspective Therapeutics, Inc. CATX |
Farallon Capital Partners L.P. | 5,064,227 7.300% |
5,064,227 (New Position) |
Filing |